The largest database of trusted experimental protocols

25 protocols using annexin 5 fitc and 7 aad

1

Doxycycline's Impact on Cell Proliferation and Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated with doxycycline alone or in combination for 72 hours. Cell proliferation was determined by CellTiter 96R AQueous One Solution Cell Proliferation assay kit (Promega, USA) according to manufacturer’s instructions. Cell apoptosis was determined by labeling apoptotic cells with Annexin V-FITC and 7-AAD (BD Biosciences, USA). The percentage of stained cells was then analyzed using flow cytometry and CXP analysis software (Beckman Coulter, USA).
+ Open protocol
+ Expand
2

Synergy and Dose-Response Assays for CLL

Check if the same lab product or an alternative is used in the 5 most similar protocols
For synergy and dose-response determinations, CLL cells were treated in 96-well plates with 6 increasing concentrations of drug for ~18 or ~72 h. Concentration ranges were selected and optimized to ensure that the exponential phase of the dose-response curve was obtained for the majority of the samples. Ranges were 0–160 µM for BEN, 0–80 µM for IDE and CLB, 0–20 µM for IBR and 0–10 µM for FLU. Synergy experiments with DRB were performed using 3 or 4 increasing doses of drug for ~18 h with the concentration ranges 0–40 µM for BEN and IDE, and 0–20 µM for DRB. The concentration of DMSO was constant between samples. After 18 or 72 h incubation, cell death was determined by flow cytometry by annexin-V-FITC and 7AAD (BD Pharmingen, San Jose, CA, USA) [41 (link)]. Cells were stained with for 15 mins with AV/7AAD and analyzed by flow cytometry using a NovoCyte flow cytometer (ACEA Biosciences, San Diego, CA, USA) with a 96-well plate adapter. Cells were considered alive when they were double-negative for AV and 7AAD. When CD19 and CD3 were analyzed in the non-CLL donor PBMCs, anti-CD19-APC or anti-CD3-APC (BD Pharmingen) were added in a triple stain with AV/7AAD. Isotype control antibodies were also run for CD19 (anti-mouse-IgG1κ, BD Pharmingen) and CD3 (anti-mouse-IgG2aκ, BD Pharmingen).
+ Open protocol
+ Expand
3

Cytotoxicity Assay for PT-112 and Cisplatin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytotoxicity assays were performed as follows: 100 µL aliquots of 3 × 104 cells were seeded per well in a 96-well plate, and 10 µM of PT-112 or cisplatin were added and incubated for 24–72 h at 37 °C. Cell death was analyzed using a FACSCalibur flow cytometer (BD, Biosciences) after incubation with annexin-V-FITC and 7-AAD (BD Biosciences, Madrid, Spain) in annexin binding buffer (140 mM NaCl, 2.5 mM CaCl2, 10 mM HEPES/NaOH, pH 7.4) for 10 min.
+ Open protocol
+ Expand
4

Quantifying Apoptosis in HSC and HSPC

Check if the same lab product or an alternative is used in the 5 most similar protocols
The apoptotic rate was quantified by TUNEL staining using in situ cell death kit (Roche, Germany) or by FACS analysis using ApoBrdU kit (Phoenix Flow Systems). Cleaved caspase 3 and cleaved caspase 8 were quantified by intracellular staining (CaspGlow 3 or CaspGlow 8 kits from Biovision). To gauge apoptosis of HSC or HSPC, cells were stained with Annexin V-FITC and 7AAD (BD Biosciences) and analyzed by FACS.
+ Open protocol
+ Expand
5

Endoxifen and VAEM Induce Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Steroid depleted cells (2 × 105/well) were treated in 6-well plates for 5 days with 0, 0.1, 1.0 and 10 μM (E/Z)-endoxifen hydrochloride. Each endoxifen concentration was combined with VAEM at concentrations of 0, 0.1, 1, 10 and 100 μg/mL in the presence or absence of 0.5 μM β-estradiol.
To detect apoptotic cell death, 2 × 105 cells were incubated with Annexin V-FITC and 7-AAD (BD Biosciences Pharmingen™, San Diego, CA, USA) at room temperature in the dark. Samples were analyzed in a FACS Calibur flow cytometer (BD Biosciences, San Jose, CA). Annexin V-FITC positive and 7-AAD negative cells were identified as early apoptotic, while late apoptotic/necrotic cells were Annexin V-FITC and 7-AAD double positive. Values were given in percent of total cell number.
+ Open protocol
+ Expand
6

Evaluating EZH2 Inhibitors in CML Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary cells from CML patients and normal controls (n = 3 each) (CD34+, CD34+CD38-, or CD34+CD38+) were cultured as above for 6 days with or without EZH2 inhibitors and/or DAS (50-150 nM), with media and drug change every three days. Viable cell numbers (trypan blue exclusion) in culture were measured every three days and fold change determined relative to input. To monitor proliferation/cell division, cells were labelled with cell trace violet (CTV; Invitrogen). Following culture, the cells were co-stained with CD34-APC to assess differentiation status and loss of CD34+. CTV and CD34 levels were analyzed by flow cytometry and the percentage recovery of input for CD34+ cells in each cell division was determined. Colcemid treatment was used to determine gating for undivided cells. To assess levels of apoptosis, cells were incubated with Annexin V-FITC and 7-AAD (556419 and 559925 respectively; BD Biosciences) and analysed by flow cytometry. Apoptotic cells were defined as Annexin V and Annexin V-7AAD positive. For colony forming cells (CFC) assays, cells cultured with or without GSK343 +/- DAS for 6 days were plated in methylcellulose (MethoCult™; StemCell Technologies) and the number and morphology of colonies determined after 12 days. Statistical analysis of differences in proliferation, CFC counts and apoptosis was performed using one sample t-tests.
+ Open protocol
+ Expand
7

Cell Proliferation and Apoptosis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell were treated with single drugor combinations for 72 hours. Cell proliferation activity was evaluated by using the CellTiter 96 AQueous One Solution Cell Proliferation assay kit (Promega, US) according to manufacturer’s instructions. Assessment of apoptosis was performed by staining cells with Annexin V-FITC and 7-AAD (BD Pharmingen, US) followed by flow cytometry on a Beckman Coulter FC500.
+ Open protocol
+ Expand
8

Multiparametric Characterization of MAIT Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed as described using the following antibodies. The anti-CD3-FITC, anti-CD161-APC, and anti-TCR Vα7.2-Brilliant Violet 421(Biolegend, USA) were used to identify MAIT cells. Anti-CD4-PE/Cy7, anti-CD8-Perp/Cy5.5, anti-CCR6-PE/Cy7, anti-CXCR6-PE, anti-IL-17A-PE, anti-Granzyme B-PE/Cy7, and anti-Perforin-PE were obtained from Biolegend (USA). Anti-CD69-PE/Cy7, anti-PD-1-PE, anti-IFN-γ-PE/Cy7, anti-TNF-α-PE were obtained from BD (USA). Appropriate isotype control antibodies were used for each staining combination. We used 7-aminoactinomycin D(7-AAD) (BD Biosciences) staining to identify dead cells. Human MR1 tetramers loaded with a potent MAIT cell ligand-5-OP-RU or 6-FP were gifted from professor Li Bai. Apoptosis was allowed to progress and two channels were used to detect annexin V- FITC and 7-AAD (BD Biosciences) to determine the proportions of apoptotic cells. Data acquisition was achieved on BD FACS Verse system (BD Biosciences), and results were analyzed using FlowJo7.6 analysis software.
+ Open protocol
+ Expand
9

Cell viability and apoptosis assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
LP-1(wt) and ANBL-6(wt) cells were treated for 4 hours with 1 or 10μM of AT-406 followed by bortezomib treatment (5 or 10nM). After 24 hours the viability was measured with the CellTiter-Glo Luminiscent Viability assay (Promega, Leiden, The Netherlands) according to manufacturer's instructions. The relative amount of viable cells was expressed as percentage of untreated cells.
Apoptosis was measured with Annexin V-FITC and 7-AAD (BD Biosciences) followed by flow cytometric analysis (FACS Canto and Diva software, BD Biosciences) according to manufacturer's instructions.
+ Open protocol
+ Expand
10

Flow Cytometry Analysis of GFP-Risk1 Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For flow cytometry analysis, 1 × 106 HeLa cells were transfected with 1 μg of pGFP-vector, pGFP-Risk1 WT, or pGFP-Risk1 H297A plasmid DNA using PolyJet. Twelve hours after transfections, cells were resuspended at a concentration of ∼0.2 × 106 cells/0.1 ml in Cytofix/Cytoperm solution and incubated for 20 min on ice with 20 μl of fluorescein isothiocyanate (FITC)-conjugated anti-active-caspase-3 Ab (BD Pharmingen). Cells were washed 2 times with Perm/Wash buffer and finally resuspended in 200 μl of blocking buffer. Alternatively, transfected cells were stained with annexin V-FITC and 7-AAD using the annexin V-FITC apoptosis detection kit by following the manufacturer’s specifications (BD Pharmingen). For experiments utilizing the PI3K inhibitors, cells were transfected as described above and incubated for 6 h followed by an additional 6 h in the presence of wortmannin (1 to 5 μM), LY294002 (1 to 2 μM), or equal volumes of the diluent DMSO as a control. The percentage of apoptotic cells was assessed by flow cytometry of Risk1+ cells using BD Biosciences FACS Accuri C6 and FCS Express V6 software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!